Uterine Growths (cont.)
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
In this Article
- What are uterine growths?
- What are uterine fibroids?
- What are the symptoms of uterine fibroids and what do they look like?
- How are uterine fibroids diagnosed?
- What is the treatment for uterine fibroids?
- Surgery for uterine fibroids
- Other medical treatment for uterine fibroids
- What are the complications of uterine fibroids?
- What is adenomyosis?
- What are the symptoms of adenomyosis and what does it look like?
- How is adenomyosis diagnosed?
- How is adenomyosis treated?
- What are uterine polyps?
- What are the symptoms of uterine polyps and what do they look like?
- How are uterine polyps diagnosed and treated?
- Find a local Obstetrician-Gynecologist in your town
Other medical treatment for uterine fibroids
It is important to remember that fibroids only require treatment if they cause bleeding or pain. There are several medical treatments available for fibroids. Birth control pills (oral contraceptives) can provide many benefits for women with fibroids. They decrease the amount of uterine bleeding by about 50% and decrease cramping pain during menstruation. They also may also decrease the risk of fibroids.
Other medical treatments include the use of drugs that turn off the production of estrogen from the ovaries (GnRH analogs). These medications are given for three to six months. When successful, they can shrink the fibroids by as much as 50%.
Mifepristone (RU-486) is an antiprogestin drug that can shrink fibroids to an extent comparable to treatment with the GnRH analogs. This drug, sometimes known as the "morning-after pill," is also used to terminate early pregnancy. Treatment with mifepristone also reduces the bleeding associated with fibroids, but this treatment can be associated with adverse side effects such as overgrowth (hyperplasia) of the endometrium (uterine lining).
Danazol (Danocrine) is an androgenic steroid hormone that has been used to reduce bleeding in women with fibroids, since this drug causes menstruation to cease. However, danazol does not appear to shrink the size of fibroids.
Letrozole (Femara), an aromatase inhibitor blocks the conversion of testosterone to estrogen and is used to treat some women with breast cancer. Preliminary studies have shown a potential role for aromatase inhibitors in the management of fibroids, but more research is needed.
Learn more about: danazol
The administration of raloxifene (Evista) (a drug used to prevent and treat osteoporosis in postmenopausal women) has been shown to decrease the size of fibroids in postmenopausal women, but results with this therapy in premenopausal women have been conflicting.
Get the latest treatment options.